Unequal randomisation can improve the efficiency of clinical trials

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.282, 2000-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategies to Measure and Improve Patient Adherence in Clinical Trials

By Matsui Doreen

Pharmaceutical Medicine, Vol. 23, Iss. 5-6, 2009-10 ,pp. : 289-297

Adis International

Access to resources Recommend Favorite

Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?

By Dhanda Ashwin D. Creed Tom J. Greenwood Rosemary Sands Bruce E. Probert Christopher S.

Inflammatory Bowel Diseases, Vol. 18, Iss. 11, 2012-11 ,pp. : 2056-2062

Blackwell Publishing

Access to resources Recommend Favorite

What can Actigraphy Add to the Concept of Labschool Design in Clinical Trials?

Current Pharmaceutical Design, Vol. 16, Iss. 22, 2010-07 ,pp. : 2434-2442

Bentham Science Publishers

Access to resources Recommend Favorite

Can Pharmacokinetic Monitoring Improve Clinical Use of Fluorouracil?

By Young A.M. Daryanani S. Kerr D.J.

Clinical Pharmacokinetics, Vol. 36, Iss. 6, 1999-06 ,pp. : 391-398

Adis International

Access to resources Recommend Favorite

What can be done to improve patient safety in phase I trials?

Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite